サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1597055

欧州の家禽用ワクチン市場の将来予測 (2031年まで) - 地域別分析：種類別、技術別、剤形別、疾患別、投与経路別、エンドユーザー別

Europe Poultry Vaccines Market Forecast to 2031 - Regional Analysis - by Type, Technology, Dosage Form, Disease, Route Of Administration, and End User

出版日
ページ情報
英文 153 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
欧州の家禽用ワクチン市場の将来予測 (2031年まで) - 地域別分析：種類別、技術別、剤形別、疾患別、投与経路別、エンドユーザー別
出版日: 2024年10月17日
発行: The Insight Partners
ページ情報: 英文 153 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の家禽用ワクチン市場は、2023年に3億2,182万米ドルと評価され、2031年には6億3,501万米ドルに達し、2023年から2031年までのCAGRは8.9%を記録する、と予測されています。

家禽産業の成長が欧州家禽用ワクチン市場を牽引

米国農務省 (USDA) の報告書によると、家禽類は過去20年間で、特に発展途上国や新興国市場において、世界で最も消費される家畜となりました。また、米国農務省の報告書によれば、家禽類は今後10年間、数量ベースで世界最大の輸入家畜商品であり続けると予想されています。鶏肉製品と輸入品に対する需要は世界的に高まっています。可処分所得の増加に伴い、消費者は高タンパク質の動物性鶏肉製品、特に鶏肉の購入にシフトしています。東南アジアやサハラ以南のアフリカなど、多くの新興経済諸国や新興市場の急速な都市化に伴い、鶏肉製品は高タンパク質を含み、高価な他の肉類をベースとした製品に比べ入手しやすいため、消費者に手頃な価格で購入できる選択肢を提供しています。鶏肉製品の需給を一致させるため、数カ国が鶏肉の国内生産に力を入れています。その中には米国、ブラジル、欧州連合 (EU)、タイが含まれ、これらは鶏肉の主要輸出国でもあります。外交問題評議会の2024年報告書によると、米国、ブラジル、EU、タイは、2021年の世界の鶏肉輸出の71%を占める。さらに、2001年から2021年にかけて、世界の鶏肉輸入量は前年比平均4%増となり、2021年の生産量は1,420万トンに達します。鶏肉製品の需要が世界的に高水準を維持し、各国が家畜の国内生産に注力していることから、ワクチン接種の需要も伸びています。このように、家禽産業の成長が家禽用ワクチン市場の成長を後押ししています。

欧州の家禽用ワクチン市場の概要

ドイツでは、家禽疾患の発生が著しく増加しています。例えば、ドイツでは2020年11月から2021年5月にかけて過去最大のHPAIアウトブレイクが発生しました。このアウトブレイクは、245羽の家禽、飼育鳥農場、1,000羽以上の野鳥に影響を与えました。さらに、ニューカッスル病に対するワクチン接種は、放し飼いにされた鳥の集団にこのウイルスが多いドイツのような国では、極めて重要な防疫対策です。ドイツの予防接種常設獣医委員会 (StIKo Vet) は、現行のワクチンの製品特性概要 (SPC) に従い、6週間ごとに弱毒生ワクチンを飲料水またはスプレーで鶏に再接種することを推奨しています。さらに、エイメリアワクチンの接種は、ケージ飼いと放し飼いの産卵鶏の両方において、レイヤー種の「雄兄弟雛」や混血雛の飼育中にエイメリア属が産生するコクシジウム症の発生を予防・管理するために重要な慣行です。したがって、これらすべての要因がドイツの家禽用ワクチン市場の成長に寄与しています。

欧州の家禽用ワクチン市場の収益と、2031年までの予測 (単位：100万米ドル)

欧州家禽用ワクチン市場セグメンテーション

欧州の家禽用ワクチン市場は、タイプ、技術、剤形、疾患、投与経路、エンドユーザー、国に分類されます。

種類別では、欧州の家禽用ワクチン市場はブロイラーとレイヤーに二分されます。2023年にはブロイラーセグメントがより大きな市場シェアを占めています。

技術面では、欧州の家禽用ワクチン市場は弱毒生ワクチン、不活化ワクチン、組み換えワクチンに分類されます。2023年には弱毒生ワクチン分野が最大の市場シェアを占めました。

剤形別では、欧州の家禽用ワクチン市場は液体ワクチン、凍結乾燥ワクチン、粉塵/粉末ワクチンに区分されます。2023年には液体ワクチンが最大の市場シェアを占めました。

疾患別では、欧州の家禽用ワクチン市場は鳥インフルエンザ、伝染性気管支炎、マレック病、鳥サルモネラ症、伝染性滑液包炎 (IBD)、ニューカッスル病、その他に分類されます。鳥インフルエンザ分野は2023年に最大の市場シェアを占めました。

投与経路別では、欧州の家禽用ワクチン市場は飲料水 (D/W)、筋肉内投与 (I/M)、皮下投与 (I/S)、その他その他に区分されます。飲料水 (D/W) セグメントが2023年に最大の市場シェアを占めました。

エンドユーザー別では、欧州の家禽用ワクチン市場は養鶏場＆孵化場、動物病院、家禽用ワクチン接種施設＆クリニックに区分されます。養鶏場・孵化場セグメントが2023年に最大の市場シェアを占めました。

国別では、欧州家禽用ワクチン市場はドイツ、スペイン、フランス、英国、イタリア、その他欧州に区分されます。2023年の欧州家禽用ワクチン市場シェアはドイツが独占しています。

Boehringer Ingelheim International GmbH、Zoetis Inc、BIOVAC、Phibro Animal Health Corp、Dechra Pharmaceuticals PLC、Elanco Animal Health Inc、Merck KGaA、Ceva、Vaccinova AB.は、欧州家禽用ワクチン市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

第4章 欧州の家禽用ワクチン市場：主な市場力学

  • 市場促進要因
    • 家禽疾患の普及浸透
    • 家禽産業の成長
  • 市場抑制要因
    • ワクチン接種の失敗と不適切な取り扱い
  • 市場機会
    • 大量ワクチン接種への政府の支援と革新的なスキーム
  • 今後の動向
    • ベクターワクチン・混合ワクチンの進歩
  • 促進要因と抑制要因の影響

第5章 欧州の家禽用ワクチン市場の分析

  • 家禽用ワクチンの市場収益 (2021～2031年)

第6章 欧州の家禽用ワクチン市場の分析：種類別

  • ブロイラー (肉用鶏)
  • レイヤー (卵用鶏)

第7章 欧州の家禽用ワクチン市場の分析：技術別

  • 生ワクチン
  • 不活化ワクチン
  • 組み換えワクチン

第8章 欧州の家禽用ワクチン市場の分析：剤形別

  • 液体ワクチン
  • フリーズドライワクチン
  • 粉末ワクチン

第9章 欧州の家禽用ワクチン市場の分析：疾患別

  • 鳥インフルエンザ
  • 鳥サルモネラ症
  • マレック病
  • 感染性気管支炎 (IB)
  • 感染性滑液包炎 (IBD)
  • ニューカッスル病
  • その他

第10章 欧州の家禽用ワクチン市場の分析：投与経路別

  • 飲料水 (D/W)
  • 筋肉内投与 (I/M)
  • 皮下投与 (S/C)
  • その他

第11章 欧州の家禽用ワクチン市場の分析：エンドユーザー別

  • 養鶏場
  • 動物病院
  • 家禽用ワクチン接種センター、診療所

第12章 欧州の家禽用ワクチン市場：国別分析

  • 欧州市場の概要
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州

第13章 業界情勢

  • 家禽用ワクチン市場における成長戦略
  • 有機的展開
  • 無機的展開

第14章 企業プロファイル

  • Boehringer Ingelheim International GmbH
  • Zoetis Inc
  • Phibro Animal Health Corp
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc
  • Merck KGaA
  • Ceva
  • Vaccinova AB

第15章 付録

図表

List Of Tables

  • Table 1. Europe Poultry Vaccines Market Segmentation
  • Table 2. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 3. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 4. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 5. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 6. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 7. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 8. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 9. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 10. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 11. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 12. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 13. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 14. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 15. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 16. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 17. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 18. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 19. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 20. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 21. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 22. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 23. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 24. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 25. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 26. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 27. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 28. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 29. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 30. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 31. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 32. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 33. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 34. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 35. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 36. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 37. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 38. Organic Developments Done by Companies
  • Table 39. Inorganic Developments Done by Companies
  • Table 40. Glossary of Terms, Poultry Vaccines Market

List Of Figures

  • Figure 1. Europe Poultry Vaccines Market Segmentation, by Country
  • Figure 2. Poultry Vaccines Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Poultry Vaccines Market Revenue (US$ Million), 2021-2031
  • Figure 5. Poultry Vaccines Market Share (%) - by Type, 2023 and 2031
  • Figure 6. Broiler: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Layer: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Poultry Vaccines Market Share (%) - by Technology, 2023 and 2031
  • Figure 9. Live Attenuated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Inactivated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Recombinant Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Poultry Vaccines Market Share (%) - by Dosage Form, 2023 and 2031
  • Figure 13. Liquid Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Freeze-Dried Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Dust/Powdered Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Poultry Vaccines Market Share (%) - by Disease, 2023 and 2031
  • Figure 17. Avian Influenza: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Avian Salmonellosis: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Marek's Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Infectious Bronchitis (IB): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Infectious Bursal Disease (IBD): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Newcastle Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Poultry Vaccines Market Share (%) - by Route of Administration, 2023 and 2031
  • Figure 25. Drinking Water (D/W): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Intramuscular (I/M): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Subcutaneous (S/C): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Poultry Vaccines Market Share (%) - by End User, 2023 and 2031
  • Figure 30. Poultry Farms: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. Veterinary Hospitals: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 32. Poultry Vaccination Centers & Clinics: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 33. Europe: Poultry Vaccine Market - Revenue by Key Countries Revenue 2023 (US$ Million)
  • Figure 34. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 35. Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 36. Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 37. France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 38. United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 39. Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 40. Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 41. Growth Strategies in the Poultry Vaccines Market
目次
Product Code: BMIRE00025385

The Europe poultry vaccines market was valued at US$ 321.82 million in 2023 and is expected to reach US$ 635.01 million by 2031; it is estimated to record a CAGR of 8.9% from 2023 to 2031.

Growing Poultry Industry Drives Europe Poultry Vaccines Market

According to the US Department of Agriculture (USDA) report, poultry has become the most consumed livestock commodity worldwide in the past two decades, particularly in developing and emerging markets. Also, poultry is expected to remain the world's largest imported livestock commodity by volume in the next 10 years as per the same USDA report. The demand for poultry products and imports is rising worldwide. As rising disposable incomes, consumers shift toward purchasing animal-based poultry products comprising high content of proteins, specifically chicken. With rapid urbanization in many developing economies and emerging markets such as Southeast Asia and Sub-Saharan Africa, poultry products provide consumers with an affordable option for purchase as poultry products comprise high protein content and are more readily available as compared to other meat-based products that are expensive. To match the demand and supply of poultry products, several countries are focusing on domestic poultry production. These countries include the US, Brazil, the European Union (EU), and Thailand, which are also major poultry exporters. According to the Council on Foreign Relations 2024 report, the US, Brazil, the European Union, and Thailand account for 71% of the world's poultry exports in 2021. Further, from 2001 to 2021, global poultry imports rose to an average of 4% year-on-year (y-o-y), reaching 14.2 million metric tons of production in 2021. With poultry products remaining high in demand worldwide and countries focusing on domestic livestock production, the demand for vaccination is also growing. Thus, the growing poultry industry fuels the poultry vaccines market growth.

Europe Poultry Vaccines Market Overview

In Germany, poultry disease outbreaks are rising significantly. For instance, Germany experienced the largest HPAI outbreak on record between November 2020 and May 2021. The outbreak affected 245 poultry; captive bird farms; and over 1,000 wild birds. Additionally, vaccination against Newcastle Disease is a crucial control measure in countries such as Germany, where the virus is common in the free-ranging bird population. The German Standing Veterinary Committee on Immunization (StIKo Vet) recommends revaccinating chickens every six weeks with attenuated live vaccines via drinking water or spray, following the Summary of Product Characteristics (SPCs) of current vaccines. Furthermore, Eimeria vaccination is an important practice in laying hens, both caged and free-range birds, to prevent and manage the possibility of suffering an outbreak of coccidiosis produced by Eimeria spp. during the rearing of "male brother chicks" of the layer breeds and mixed genetics chicks. Therefore, all these factors are contributing to the growth of the poultry vaccines market in Germany.

Europe Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)

Europe Poultry Vaccines Market Segmentation

The Europe poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.

Based on type, the Europe poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.

In terms of technology, the Europe poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.

By dosage form, the Europe poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.

Based on disease, the Europe poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023.

In terms of route of administration, the Europe poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.

Based on end user, the Europe poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.

By country, the Europe poultry vaccines market is segmented into Germany, Spain, France, the UK, Italy, and the Rest of Europe. Germany dominated the Europe poultry vaccines market share in 2023.

Boehringer Ingelheim International GmbH, Zoetis Inc, BIOVAC, Phibro Animal Health Corp, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, and Vaccinova AB. are some of the leading companies operating in the Europe poultry vaccines market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

4. Europe Poultry Vaccines Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Poultry Diseases
    • 4.1.2 Growing Poultry Industry
  • 4.2 Market Restraints
    • 4.2.1 Vaccination Failure and Improper Handling
  • 4.3 Market Opportunities
    • 4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
  • 4.4 Future Trends
    • 4.4.1 Advancements in Vectored and Combination Vaccines
  • 4.5 Impact of Drivers and Restraints:

5. Europe Poultry Vaccines Market Analysis

  • 5.1 Poultry Vaccines Market Revenue (US$ Million), 2021-2031

6. Europe Poultry Vaccines Market Analysis - by Type

  • 6.1 Overview
  • 6.2 Broiler
    • 6.2.1 Overview
    • 6.2.2 Broiler: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Layer
    • 6.3.1 Overview
    • 6.3.2 Layer: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Poultry Vaccines Market Analysis - by Technology

  • 7.1 Overview
  • 7.2 Live Attenuated Vaccines
    • 7.2.1 Overview
    • 7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Inactivated Vaccines
    • 7.3.1 Overview
    • 7.3.2 Inactivated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Recombinant Vaccines
    • 7.4.1 Overview
    • 7.4.2 Recombinant Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Poultry Vaccines Market Analysis - by Dosage Form

  • 8.1 Overview
  • 8.2 Liquid Vaccines
    • 8.2.1 Overview
    • 8.2.2 Liquid Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Freeze-Dried Vaccines
    • 8.3.1 Overview
    • 8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Dust/Powdered Vaccines
    • 8.4.1 Overview
    • 8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Poultry Vaccines Market Analysis - by Disease

  • 9.1 Overview
  • 9.2 Avian Influenza
    • 9.2.1 Overview
    • 9.2.2 Avian Influenza: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Avian Salmonellosis
    • 9.3.1 Overview
    • 9.3.2 Avian Salmonellosis: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Marek's Disease
    • 9.4.1 Overview
    • 9.4.2 Marek's Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Infectious Bronchitis (IB)
    • 9.5.1 Overview
    • 9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Infectious Bursal Disease (IBD)
    • 9.6.1 Overview
    • 9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.7 Newcastle Disease
    • 9.7.1 Overview
    • 9.7.2 Newcastle Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.8 Others
    • 9.8.1 Overview
    • 9.8.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Poultry Vaccines Market Analysis - by Route of Administration

  • 10.1 Overview
  • 10.2 Drinking Water (D/W)
    • 10.2.1 Overview
    • 10.2.2 Drinking Water (D/W): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Intramuscular (I/M)
    • 10.3.1 Overview
    • 10.3.2 Intramuscular (I/M): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Subcutaneous (S/C)
    • 10.4.1 Overview
    • 10.4.2 Subcutaneous (S/C): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

11. Europe Poultry Vaccines Market Analysis - by End User

  • 11.1 Overview
  • 11.2 Poultry Farms
    • 11.2.1 Overview
    • 11.2.2 Poultry Farms: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Veterinary Hospitals
    • 11.3.1 Overview
    • 11.3.2 Veterinary Hospitals: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Poultry Vaccination Centers & Clinics
    • 11.4.1 Overview
    • 11.4.2 Poultry Vaccination Centers & Clinics: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

12. Europe Poultry Vaccines Market - Country Analysis

  • 12.1 Europe Market Overview
    • 12.1.1 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
      • 12.1.1.1 Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.1.1 Overview
        • 12.1.1.1.2 Germany: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.1.3 Germany: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.1.4 Germany: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.1.5 Germany: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.1.6 Germany: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.1.7 Germany: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.2 Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.2.1 Overview
        • 12.1.1.2.2 Spain: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.2.3 Spain: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.2.4 Spain: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.2.5 Spain: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.2.6 Spain: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.2.7 Spain: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.3 France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.3.1 Overview
        • 12.1.1.3.2 France: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.3.3 France: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.3.4 France: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.3.5 France: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.3.6 France: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.3.7 France: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.4 United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.4.1 Overview
        • 12.1.1.4.2 United Kingdom: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.4.3 United Kingdom: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.4.4 United Kingdom: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.4.5 United Kingdom: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.4.6 United Kingdom: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.4.7 United Kingdom: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.5 Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.5.1 Overview
        • 12.1.1.5.2 Italy: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.5.3 Italy: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.5.4 Italy: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.5.5 Italy: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.5.6 Italy: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.5.7 Italy: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.6 Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.6.1 Overview
        • 12.1.1.6.2 Rest of Europe: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.6.3 Rest of Europe: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.6.4 Rest of Europe: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.6.5 Rest of Europe: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.6.6 Rest of Europe: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.6.7 Rest of Europe: Poultry Vaccines Market Breakdown by End User

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in the Poultry Vaccines Market
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.1 Inorganic Developments
    • 13.1.1 Overview

14. Company Profiles

  • 14.1 Boehringer Ingelheim International GmbH
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Zoetis Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Phibro Animal Health Corp
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Dechra Pharmaceuticals PLC
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Elanco Animal Health Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Merck KGaA
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Ceva
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Vaccinova AB
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms